CD40LG and B-cell chronic lymphocytic leukemia: Cross-linking the surface IgM receptor with the use of anti-IgM antibodies in vitro results in a heterogeneous response among CLL cases, as assessed by tyrosine phosphorylation, Ca2+ mobilization or even by measuring survival after Ig cross-linking [8].